Abstract:Diabetes mellitus (DM) represents a problem for the healthcare system worldwide. DM has very serious complications such as blindness, kidney failure, and cardiovascular disease. In addition to the very bad socioeconomic impacts, it influences patients and their families and communities. The global costs of DM and its complications are huge and expected to rise by the year 2030. DM is caused by genetic and environmental risk factors. Genetic testing will aid in early diagnosis and identification of susceptible individuals or populations using ATP-sensitive potassium (KATP) channels present in different tissues such as the pancreas, myocardium, myocytes, and nervous tissues. The channels respond to different concentrations of blood sugar, stimulation by hormones, or ischemic conditions. In pancreatic cells, they regulate the secretion of insulin and glucagon. Mutations in the KCNJ11 gene that encodes the Kir6.2 protein (a major constituent of KATP channels) were reported to be associated with Type 2 DM, neonatal diabetes mellitus (NDM), and maturity-onset diabetes of the young (MODY). Kir6.2 harbors binding sites for ATP and phosphatidylinositol 4,5-diphosphate (PIP2). The ATP inhibits the KATP channel, while the (PIP2) activates it. A Kir6.2 mutation at tyrosine330 (Y330) was demonstrated to reduce ATP inhibition and predisposes to NDM. In this study, we examined the effect of mutations on the Kir6.2 structure using bioinformatics tools and molecular dynamic simulations (SIFT, PolyPhen, SNAP2, PANTHER, PhD&SNP, SNP&Go, I-Mutant, MuPro, MutPred, ConSurf, HOPE, and GROMACS). Our results indicated that M199R, R201H, R206H, and Y330H mutations influence Kir6.2 structure and function and therefore may cause DM. We conclude that MD simulations are useful techniques to predict the effects of mutations on protein structure. In addition, the M199R, R201H, R206H, and Y330H variant in the Kir6.2 protein may be associated with DM. These results require further verification in protein–protein interactions, Kir6.2 function, and case-control studies.

Kir 6.2 activating mutation and neonatal diabetes

A Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cells

Permanent Neonatal Diabetes Mellitus in China

Neonatal Diabetes Mellitus: a Clinical Analysis of 13 Cases

A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life

Expression of Insulin and ATP-sensitive Potassium (KATP) Channels in Pancreas of Neonatal Rats with Low Birth Weight

Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature

Neonatal Hyperinsulinism with an ABCC8 Mutation: A Case Report

Implication of Oxygen-Regulated Protein 150 (ORP150) in Apoptosis Induced by Proteasome Inhibitors in Human Thyroid Cancer Cells

22 Pharmacogenetics for T 2 DM and Anti-Diabetic Drugs

Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas

Gain of Function Mutation in K(ATP) Channels and Resulting Upregulation of Coupling Conductance are Partners in Crime in the Impairment of Ca 2+ Oscillations in Pancreatic ß-cells

Pharmacogenetics for T2DM and Anti-Diabetic Drugs

A novel mutation in INS gene linked to permanent neonatal diabetes mellitus

Molecular Dynamics Simulation of Kir6.2 Variants Reveals Potential Association with Diabetes Mellitus

A Novel C.125 T>G (p.val42gly) Mutation in the Human INS Gene Leads to Neonatal Diabetes Mellitus Via a Decrease in Insulin Synthesis.

From Hyper- to Hypoinsulinemia and Diabetes: Effect of KCNH6 on Insulin Secretion.

Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes

Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity

Identification of Glucokinase Mutations in Subjects with Gestational Diabetes Mellitus.

Neonatal diabetes mellitus around the world: Update 2024